The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 13, 2018

Filed:

Jun. 17, 2015
Applicant:

Sulfateq B.v., Groningen, NL;

Inventors:

Adrianus Cornelis Van der Graaf, Groningen, NL;

Martina Schmidt, Haren, NL;

Gerrit Jan Willem Euverink, Haren, NL;

Hermanus Meurs, Groningen, NL;

Robert Henk Henning, Groningen, NL;

Assignee:

Sulfateq B.V., Groningen, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/496 (2006.01); A61K 31/353 (2006.01); A61K 31/4025 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61K 9/0075 (2013.01); A61K 31/353 (2013.01); A61K 31/4025 (2013.01);
Abstract

The present invention relates to compounds for the treatment of chronic obstructive airway diseases such as chronic obstructive pulmonary disease (COPD) or asthma or bronchiectasis. The present invention further relates to drug delivery devices suitable to be used in the treatment of chronic obstructive airway diseases such as a nebulizer comprising the present compounds. Specifically, the present invention relates to (6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(piperazin-1-yl)methanone or N,6-di-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide or a pharmaceutically acceptable salt or base thereof for use in the treatment of chronic obstructive airway diseases, preferably chronic obstructive pulmonary disease (COPD) or asthma or bronchiectasis, more preferably chronic obstructive pulmonary disease (COPD).


Find Patent Forward Citations

Loading…